Japan Breast Augmentation Market - Size, Share, and Forecast (2025-2033)

Overview

The Japan breast augmentation market reached US$ 131.14 million in 2024 and is expected to reach US$ 227.43 million by 2033, growing at a CAGR of 7.10 % during the forecast period 2025-2033.

Breast augmentation is a surgical procedure designed to enhance the size, shape, and overall appearance of the breasts. This procedure involves the placement of implants or the transfer of fat tissue to improve the aesthetics of the breast. It is typically performed for cosmetic reasons, but it can also serve reconstructive purposes, such as following a mastectomy or correcting congenital deformities.

Breast augmentation can offer dramatic improvements in a person’s appearance, but candidates need to have realistic expectations, understand the risks, and consult with an experienced plastic surgeon to determine the most suitable approach for their individual goals.

Executive Summary 

Market Dynamics: Drivers & Restraints

Rising Demand for Cosmetic Procedures in Japan

The rising demand for cosmetic procedures in Japan is a significant factor driving the growth of the breast augmentation market. Cosmetic surgery has become more widely accepted and sought after due to a combination of cultural shifts, advancements in medical technology and increased awareness of body image. As a result, more women are opting for procedures like breast augmentation to enhance their appearance and boost self-esteem.

For instance, a total of 265,733 cosmetic surgical procedures were performed in Japan in 2021 including breast augmentation procedures. Traditional Japanese beauty ideals emphasize a slim, youthful and proportionate figure, and increasingly, fuller breasts are becoming a symbol of attractiveness. In recent years, cosmetic surgery has gained greater acceptance, especially in urban areas, with many women choosing aesthetic enhancement to meet their personal beauty goals.

The Japanese market has benefited from innovations in implant technology. The introduction of gummy bear implants (highly cohesive silicone implants) and textured implants has led to safer, more natural-looking results. These advancements in implant design are attracting more patients who seek aesthetic improvement without the risks previously associated with older implant types.

Potential Complications and Health Concerns

While the breast augmentation market in Japan is experiencing strong growth, several complications and health concerns can hamper its expansion. These challenges, ranging from physical risks associated with the procedure to psychological issues, contribute to hesitations and concerns among potential patients, ultimately impacting market growth.

Breast augmentation, particularly when implants are used, comes with the risk of complications that can create hesitancy among potential patients. The primary concerns include the formation of tight scar tissue around the implant, which can cause the breast to harden and distort its shape. Capsular contracture is one of the most common complications following breast augmentation surgeries.

Implants, especially saline implants, can rupture over time, leading to deflation or leakage. Silicone implants, while considered safer, can also experience issues such as silent ruptures, where the rupture may not be immediately detected. As with any surgical procedure, breast augmentation carries a risk of infection. This is particularly concerning if implants are involved, as the risk can lead to more severe health complications.

Segment Analysis

The Japan breast augmentation market is segmented based on augmentation type, application, and end-user.

Augmentation Type:

The breast implants segment in the augmentation type is expected to dominate the Japanese breast augmentation market  share

The breast implants segment in the Japan breast augmentation market was valued at US$ 74.00 - 84.00 million in 2024 and is estimated to reach US$ XX Million by 2033, growing at a CAGR of 12.5 - 13.5% during the forecast period from 2025-2033.

The breast implants segment is the dominant segment in Japan's breast augmentation market due to several factors, including the advanced technology of breast implants, cultural preferences and high demand for cosmetic enhancement procedures. While fat transfer and other non-implant alternatives exist, breast implants continue to be the preferred choice for most women seeking aesthetic improvement through surgery.

For instance, in August 2020, Sientra, Inc., a diversified global medical aesthetics company, announced that it had received approval from Japan’s Pharmaceutical and Medical Device Agency (”PDMA”) to market the Company’s entire OPUS line of breast implants in Japan. Sientra will market the complete portfolio of OPUS breast implants in Japan through its local partner Medical U&A, Inc., a leading provider of surgical and medical devices in the fields of plastic and reconstructive surgery. Medical U&A will sell Sientra’s implants through a dedicated sales force to over 2,000 hospitals and clinics across Japan.

Japan has seen significant advancements in implant technology, especially with the introduction of gummy bear implants (highly cohesive silicone implants). These implants are designed to feel more natural and retain their shape better than older-generation implants. The availability of silicone gel implants, which offer a more natural texture and feel compared to saline implants, has also contributed to the continued dominance of breast implants. Japanese women, known for their preference for subtle and natural-looking outcomes, often favor these implants for their ability to mimic the look and feel of real breasts more effectively.Top of Form

Competitive Landscape

The major players in the Japan breast augmentation market include Establishment Labs Inc., AbbVie Inc., Sientra, Inc., Johnson & Johnson, and GC Aesthetics among others.

Key Developments

• In April 2023, Establishment Labs Holdings Inc. launched Mia Femtech (Mia) in Japan as part of its strategy to revolutionize breast aesthetics. This innovation represents a new, minimally invasive alternative to traditional breast augmentation, addressing the concerns of women who are hesitant about conventional procedures due to factors such as stigma, surgical risks, or long recovery periods.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan breast augmentation market report delivers a detailed analysis with 60+ key tables, more than 50  visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Suggestions for Related Report

• Global Breast Augmentation Market
• Global Breast Aesthetic Surgery Market
• US Round-Shaped Breast Implants Market

For more medical devices-related reports, please click here